[bioundgrd] Innovation in Biotech Business Modelse - April 14th NOON

[Janice Chang]

>
>Date: Fri, 11 Apr 2008 11:39:22 -0400
>From: "Adam Weinstein" <adam.weinstein at sloan.mit.edu>
>To: jdchang at mit.edu, dalia at mit.edu
>Subject: Upcoming talk at Sloan
>
>The Biomedical Business Club presents: Skip Irving, Partner and 
>Managing Director, Health Advances
>"Innovation in Biotech Business Models"
>
>When: Monday, April 14th 2008
>Where: e51-345, 12NOON
>Lunch will be served
>
>Skip Irving is Partner and Managing Director of Health Advances, a 
>leading life sciences consulting firm. Skip will give an overview of 
>recent innovations in biotech business models, from non-profit 
>investment to new deal structures in this space.
>
>Skip has spent more than twenty years advising companies on business 
>strategy, technology commercialization, R&D planning, and mergers 
>and acquisitions in the medical products industry. A pharmacist by 
>training, Skip's practice focuses on pharmaceuticals and 
>biotechnology.
>
>Prior to joining Health Advances, Skip helped found seven life 
>sciences companies as Vice President for Commercial Development at 
>the Massachusetts Biotechnology Research Institute (MBRI). Earlier 
>in his career, Skip founded and led the pharmaceutical consulting 
>practice for Arthur D. Little, Inc. He has also previously worked in 
>manufacturing and product development for AstraZeneca, and he 
>contributed to the founding of t. Breeders, Inc., which eventually 
>became ViaCell, Inc. and was purchased by Perkin Elmer.
>
>Leveraging his knowledge of the biopharma industry, Skip has 
>developed a practice advising not-for-profit disease organizations 
>on their investments and relationships with industry. He serves on 
>the Board of Directors for the Michael J. Fox Foundation for 
>Parkinson's Research.
>
>
>
>
>--
>MBA/SM Candidate, Class of 2009
>Harvard-MIT Biomedical Enterprise Program
>Mobile: 631-946-9138